Dr. Sylvia Wojczewski and Dr. Hüseyin Aygün are the founders and managing directors of this owner-managed company. They co-founded BioSpring back in 1997 while completing their doctoral studies in chemistry at Goethe University in Frankfurt, and have led the company to become one of the largest manufacturers of synthetic nucleic acids in the world. It is their tremendous dedication to research, professionalism, and agility that has led BioSpring to this level of success. Alongside clients, Dr. Wojczewski and Dr. Aygün have the unwavering ambition to fully harness the potential of nucleic acids for global human health.
Dr. Sylvia Wojczewski
"I co-founded BioSpring in 1997 to pursue my passion for both innovative technologies and the potential of therapeutic oligonucleotides. Based in Frankfurt am Main, Germany, BioSpring is now an industry leader in production and analysis of high-quality nucleic acids for therapeutic and diagnostic applications, providing a single-source solution for the research, clinical, and commercial pursuits of biotechnology and major pharmaceutical companies around the globe. I also proudly serve on the board of directors at BIO Deutschland e.V. to support and promote the development of the biotechnology industry in Germany."
Dr. Hüseyin Aygün
"In 1997, I co-founded BioSpring, which is based today in Frankfurt am Main, Germany. BioSpring is now an industry leader in production and analysis of high-quality nucleic acids for therapeutic and diagnostic applications and supports research, clinical, and commercial pursuits of biotechnology and major pharmaceutical companies around the globe, by providing a single-source solution."
